Fresenius Medical Care AG Fresenius Medical Care AG : Release of a capital market information

Fresenius Medical Care AG: Share buyback

Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

Share buyback – Interim Report

In the period from July 27, 2026 to July 31, 2026 (each inclusive), 98,738 shares were bought back within the framework of the first tranche of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on May 28, 2026, pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

Shares were bought back as follows:

Date	Acquired shares (number)	Weighted average price (in EUR)	Transaction volume (in EUR)	Trading venue
27 July 2026	1,000	43.6692	43,669.20	XETR
28 July 2026	51,238	43.2877	2,217,975.17	XETR
29 July 2026	15,500	43.7504	678,131.20	XETR
30 July 2026	30,000	44.0330	1,320,990.00	XETR
31 July 2026	1,000	44.6111	44,611.10	XETR

A total of 3,633,778 shares has been acquired within the framework of the first tranche of the share buyback.

The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG.

Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.